CRISPR/ Gene editing
Small molecules such as 4-Hydroxytamoxifen ≥70% Z isomer can enhance the overall efficiency and targeting precision of CRISPR/Cas-9-mediated genome editing. Researchers can save up to 50% on small molecules for CRISPR / Cas9 genome editing - they are up to half the price of other suppliers.
View resources: Small Molecules for Genome Editing | Inducible CreER and CRISPR/Cas9 genome engineering techniques using small molecules
SR 95531 hydrobromide (Gabazine) (HB0901)
Description:Selective, competitive GABAA receptor antagonist
Purity:>98%
(S)-(-)-Sulpiride (HB1836)
Description:Selective D2-like receptor antagonist. Active enantiomer.
Purity:>99%
Talampanel (HB0600)
Description:Selective, non-competitive AMPA / kainate receptor antagonist
Purity:>98%
TCN 201 (HB0604)
Description:Potent, non-competitive GluN2A subunit selective NMDA receptor antagonist
Purity:>99%
Tropisetron hydrochloride (HB2827)
Description:Potent 5-HT3 receptor antagonist. Also α7 nAChR partial agonist. Activates α7Q79G-GlyR chimeric ion channels.
Purity:>99%
UBP 302 (HB0627)
Description:Potent, selective GluK1 subunit selective kainate receptor antagonist
Purity:>98%
UBP 310 (HB0628)
Description:Potent, selective GluK1 / GluK3 subunit selective kainate receptor antagonist
Purity:>98%